{
    "2019-10-28": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Justice Department issues grand jury subpoenas in J&J opioid probe: filing",
                "features": {
                    "keywords": [
                        "Justice Department",
                        "grand jury",
                        "subpoenas",
                        "J&J",
                        "opioid probe"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "Can Johnson and Johnson Survive this Latest Controversy?",
                "features": {
                    "keywords": [
                        "Johnson and Johnson",
                        "Survive",
                        "Controversy"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-19",
                "original_text": "Dow up 110 points on gains in shares of Microsoft, Goldman Sachs",
                "features": {
                    "keywords": [
                        "Dow",
                        "up",
                        "points",
                        "gains",
                        "Microsoft",
                        "Goldman Sachs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "Imbruvica to Offset Humira Woes in AbbVie (ABBV) Q3 Earnings?",
                "features": {
                    "keywords": [
                        "Imbruvica",
                        "Offset",
                        "Humira",
                        "Woes",
                        "AbbVie",
                        "Q3 Earnings"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}